4-4197213-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_177998.3(OTOP1):āc.1621A>Gā(p.Lys541Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,612,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_177998.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOP1 | NM_177998.3 | c.1621A>G | p.Lys541Glu | missense_variant | 5/6 | ENST00000296358.5 | NP_819056.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOP1 | ENST00000296358.5 | c.1621A>G | p.Lys541Glu | missense_variant | 5/6 | 1 | NM_177998.3 | ENSP00000296358.4 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150464Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247734Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134156
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461798Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727180
GnomAD4 genome AF: 0.0000332 AC: 5AN: 150562Hom.: 0 Cov.: 32 AF XY: 0.0000408 AC XY: 3AN XY: 73540
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 19, 2024 | The c.1621A>G (p.K541E) alteration is located in exon 5 (coding exon 5) of the OTOP1 gene. This alteration results from a A to G substitution at nucleotide position 1621, causing the lysine (K) at amino acid position 541 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at